SARS-CoV-2 Infection and Vaccination Outcomes in Multiple Sclerosis.

Brunn, Jenna A; Dunietz, Galit Levi; Romeo, Andrew R; Braley, Tiffany J

Brunn, Jenna A; Dunietz, Galit Levi; Romeo, Andrew R; Braley, Tiffany J.

Afiliação

Brunn JA; Michigan Medicine (JAB), Department of Neurology, University of Michigan, Ann Arbor; Michigan Medicine (GLD, TJB), Department of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor; and Michigan Medicine (ARR, TJB), Department of Neurology, Division of Multiple Sclerosis and Cli
Dunietz GL; Michigan Medicine (JAB), Department of Neurology, University of Michigan, Ann Arbor; Michigan Medicine (GLD, TJB), Department of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor; and Michigan Medicine (ARR, TJB), Department of Neurology, Division of Multiple Sclerosis and Cli
Romeo AR; Michigan Medicine (JAB), Department of Neurology, University of Michigan, Ann Arbor; Michigan Medicine (GLD, TJB), Department of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor; and Michigan Medicine (ARR, TJB), Department of Neurology, Division of Multiple Sclerosis and Cli
Braley TJ; Michigan Medicine (JAB), Department of Neurology, University of Michigan, Ann Arbor; Michigan Medicine (GLD, TJB), Department of Neurology, Division of Sleep Medicine, University of Michigan, Ann Arbor; and Michigan Medicine (ARR, TJB), Department of Neurology, Division of Multiple Sclerosis and Cli

Neurol Clin Pract ; 12(3): e14-e21, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35747550

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Neurol Clin Pract Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google